Research progress of regorafenib in the treatment of colorectal cancer

Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 9

Abstract

Colorectal cancer (CRC) is a common malignant tumor of digestive tract with an increasing incidence and mortality worldwide, and most patients have lost the opportunity of surgical treatment once diagnosed. With the continuous development of precision targeted therapy, anti-angiogenesis targeted drugs have achieved good therapeutic effect in the treatment of advanced CRC. Regorafenib is a multi-target oral tyrosine kinase inhibitor, which can improve the tumor immune microenvironment by regulating tumor-associated macrophage, vascular endothelial growth factor receptor, and has a synergistic effect with immunotherapy. This article reviews the progress of basic and clinical research on regorafenib in the field of CRC.

Authors and Affiliations

CHEN Yixuan, LEI Xuefen, ZHANG Meng, CHEN Qian, CHEN Haixia

Keywords

Related Articles

Progress in Chinese medicine treatment of gastrointestinal dysfunction after gastric cancer surgery

Surgery is the most important method for the treatment of gastric cancer, but a series of complications will occur after gastric cancer surgery, the most common complication is gastrointestinal dysfunction, affecting the...

Comparison of analgesic effects between ultrasound-guided thoracic paravertebral block and intercostal nerve block in patients with multiple rib fractures

"<b>Objective</b> To compare the analgesic effects and safety of ultransound-guided thoracic paravertebral block (TPVB) and intercostal nerve block (INB) in patients with unilateral multiple rib fractures. <b>Methods<...

Establishment of a predictive model for somatosensory evoked potentials during decompression laminectomy

<b>Objective</b> To explore the influencing factors affecting somatosensory evoked potential (SEP) during decompression laminectomy and to establish a prediction model. b>Methods</b> The SEP monitoring data from 120 pa...

Construction of a preoperative lymph node metastasis risk prediction model for colorectal cancer

Objective To investigate the independent risk factors among preoperative systemic inflammatory indicators associated with lymph node metastasis (LNM) in patients with colorectal cancer (CRC) and to construct and validate...

Effect of different administration methods of esketamine on postoperative pain after thoracoscopic lung surgery

Objective To investigate the effect of itravenous injection or infuson of esketamine on postoperative pain in patients undergoing thoracoscopic lung surgery. Methods A total of 90 patients who underwent elective thorac...

Download PDF file
  • EP ID EP745448
  • DOI 10.13429/j.cnki.cjcr.2024.09.002
  • Views 1
  • Downloads 0

How To Cite

CHEN Yixuan, LEI Xuefen, ZHANG Meng, CHEN Qian, CHEN Haixia (2024). Research progress of regorafenib in the treatment of colorectal cancer. Chinese Journal of Clinical Research, 37(9), -. https://europub.co.uk/articles/-A-745448